Sana Biotechnology, Inc. (SANA)
$2.33-3.32%Close
SELLCRISIS · day 27
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $648M
- Beta
- 2.19
- P/E (TTM)
- -3.07
- Short % float
- 22.29%
- Days to cover
- 9.0
- SI change
- -6.4%
- 1W
- -14.34%
- 1M
- -26.27%
- vs SPY 1W
- -14.20%
- vs SPY 1M
- -28.77%
Industry peers
FMP comparable companies · ranked by market cap
- CRSPSELLCRISPR Therapeutics AG$4.9BCRISISQ 20$50.44+0.24%
- LEGNSELLLegend Biotech Corporation$3.5BRECOVERYQ 2$18.71+6.49%
- BEAMBUYBeam Therapeutics Inc.$2.5BRECOVERYQ 13$24.60-3.19%
- NTLASELLIntellia Therapeutics, Inc.$1.8BRECOVERYQ 3$12.60-4.03%
- CGEMSELLCullinan Therapeutics, Inc.$950MCRISISQ 1$15.46-3.26%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on SANA?
- LOPJLB’s latest quantitative signal on Sana Biotechnology, Inc. (SANA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is SANA in?
- Sana Biotechnology, Inc. (SANA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Sana Biotechnology, Inc. (SANA) do?
- Sana Biotechnology, Inc. is a biotechnology firm focused on creating treatments using engineered cells. The company develops advanced ex vivo and in vivo cell engineering platforms to address a range of conditions with significant unmet medical needs, including various cancers, diabetes, central nervous system disorders, cardiovascular diseases, and genetic illnesses. Its portfolio of drug cand…